Semi-quantification of the number of leucocytes, epithelial cells, myofibroblasts and endothelial cells undergoing apoptosis in the model of BLM-induced lung fibrosis. Co-staining with specific cell markers identified the apoptotic cells (cleaved caspase 3+) as EPC (E-cadherin) and leucocytes (CD45+). Data are expressed as mean ± SD, n = 3 (each). (TIF 422 kb
Figure S1. Flow cytometry analysis of BALF samples. For the gating strategy, lymphocytes were distin...
Figure S1. Immunolocalization of CD45+ and CD133+cells in pulmonary arteries. (a) Representative mic...
Figure S1. Gating strategy used during FACS analysis to identify the analyzed leukocytes subsets. Im...
Semi-quantification of the number of leucocytes, epithelial cells, myofibroblasts and endothelial ce...
Background Given the need for early detection of organ involvement in systemic sclerosis, we evalua...
Relative decline in FVC % predicted (compared with baseline) over 12Â months (DOCX 15 kb
Complete overview collagen-1 and CD15 staining on CD45+/Col-1+ cells and controls. Immunocytochemica...
Representative data from a subject at baseline and 12 months in the SLS I. Subject was 61 years old ...
Gating strategies for the detection of circulating M1, M2 and mixed M1/M2 cells in systemic sclerosi...
Table S1a. Differential cell counts of leukocytes of in BAL fluid, given in number of cells/ml*104. ...
Study subject characteristic. *Median (minimum-maximum). † Anonymous blood donors. ‡ Two of these pa...
Figure S1. PET imaging with apoptotic radiotracers. Representative PET images with (A) 18F-ICMT-11 a...
Characteristics of patients and the healthy subjects used for experiments. Data are mean ± standard ...
The general morphology of fresh lung tissue in each group. (A) control group; (B) silica model group...
Table S1. Spearman’s correlation analysis between CT parameters and sputum markers (all sputum sampl...
Figure S1. Flow cytometry analysis of BALF samples. For the gating strategy, lymphocytes were distin...
Figure S1. Immunolocalization of CD45+ and CD133+cells in pulmonary arteries. (a) Representative mic...
Figure S1. Gating strategy used during FACS analysis to identify the analyzed leukocytes subsets. Im...
Semi-quantification of the number of leucocytes, epithelial cells, myofibroblasts and endothelial ce...
Background Given the need for early detection of organ involvement in systemic sclerosis, we evalua...
Relative decline in FVC % predicted (compared with baseline) over 12Â months (DOCX 15 kb
Complete overview collagen-1 and CD15 staining on CD45+/Col-1+ cells and controls. Immunocytochemica...
Representative data from a subject at baseline and 12 months in the SLS I. Subject was 61 years old ...
Gating strategies for the detection of circulating M1, M2 and mixed M1/M2 cells in systemic sclerosi...
Table S1a. Differential cell counts of leukocytes of in BAL fluid, given in number of cells/ml*104. ...
Study subject characteristic. *Median (minimum-maximum). † Anonymous blood donors. ‡ Two of these pa...
Figure S1. PET imaging with apoptotic radiotracers. Representative PET images with (A) 18F-ICMT-11 a...
Characteristics of patients and the healthy subjects used for experiments. Data are mean ± standard ...
The general morphology of fresh lung tissue in each group. (A) control group; (B) silica model group...
Table S1. Spearman’s correlation analysis between CT parameters and sputum markers (all sputum sampl...
Figure S1. Flow cytometry analysis of BALF samples. For the gating strategy, lymphocytes were distin...
Figure S1. Immunolocalization of CD45+ and CD133+cells in pulmonary arteries. (a) Representative mic...
Figure S1. Gating strategy used during FACS analysis to identify the analyzed leukocytes subsets. Im...